Acute biliary pancreatitis: a prospective cohort study

Detalhes bibliográficos
Autor(a) principal: B. Osvaldt, Alessandro
Data de Publicação: 2022
Outros Autores: Viero, Priscila, T. B. da Costa, Mário Sérgio, P. Bersch, Vivian, Wendt, Luiz Roberto, Rohde, Luiz
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/125708
Resumo: OBJECTIVE: Acute biliary pancreatitis (ABP) is a disease with high morbidity and mortality rates but poorly studied in Brazil. Our objective was to describe the differential  diagnosis for the etiology of ABP and assess the severity and treatment of the disease at the Hospital de Clínicas de Porto Alegre, in 1999. MATERIALS AND METHODS: We carried out a cohort, prospective study in 65 (78.4%) patients who presented amylase greater than 440 mg/dl and acute biliary pancreatitis (ABP). We assessed biliary Ranson scores, modified Glasgow scores, APACHE-II and APACHE-O of our population in order to determine the severity of the disease. These scores and values were followed-up during the evolution of the disease. RESULTS: Twelve patients presented clinical evolution of the disease. The systemic complications were kidney failure (n=4), respiratory failure (n=3), shock (n=3), and sepsis associated with cholangitis (n=1). The local complications, in turn, were peripancreatic fluid collection (n=3), pancreatic necroses (n=3), pancreatic pseudocyst (n=1), and pancreatic fistula (n=1). There was only one case of death, which occurred due to acute myocardial infarction and refractory hypocalcemia. The prognostic criteria, according to the number of positive parameters, indicated relative risk (RR) from 4.7 to 11.2, sensitivity from 33.3% to 83.3%, specificity from 79.2% to 98.1%, positive predictive value from 45.0% to 83.3%, negative predictive value from 86.4% to 95.5%, and accuracy from 78.5% to 89.6%. The parameters that presented a separate correlation with severity were white blood cell count >18,000/mm3 , LDH >400 UI/l, 10% decrease in hematocrit levels, serum calcium levels <8 mg/dl, increase in urea nitrogen levels >2 mg/dl, AST >200 mg/dl, LDH >600 UI/l, white cell count >15,000/mm3 , urea >45 mg/dl, arterial pH £7.33 or ³7.49, creatinine levels £0.6 or ³1.4, hematocrit levels £30 or ³45,9, white cell count £3,000 or ³14,900. CONCLUSION: biliary Ranson scores, modified Glasgow scores, APACHE-II and APACHE-O presented good sensitivity and specificity. Multidisciplinary protocols should be implemented in order to achieve optimal treatment results. 
id UFRGS-20_7b7da5a2b1e1957daadfe785ebf8079a
oai_identifier_str oai:seer.ufrgs.br:article/125708
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Acute biliary pancreatitis: a prospective cohort studyPancreatite aguda biliar: um estudo de coorte prospectivoPancreatite agudabiliargravidadeprognósticoSeverityacute pancreatitisbiliary pancreatitisOBJECTIVE: Acute biliary pancreatitis (ABP) is a disease with high morbidity and mortality rates but poorly studied in Brazil. Our objective was to describe the differential  diagnosis for the etiology of ABP and assess the severity and treatment of the disease at the Hospital de Clínicas de Porto Alegre, in 1999. MATERIALS AND METHODS: We carried out a cohort, prospective study in 65 (78.4%) patients who presented amylase greater than 440 mg/dl and acute biliary pancreatitis (ABP). We assessed biliary Ranson scores, modified Glasgow scores, APACHE-II and APACHE-O of our population in order to determine the severity of the disease. These scores and values were followed-up during the evolution of the disease. RESULTS: Twelve patients presented clinical evolution of the disease. The systemic complications were kidney failure (n=4), respiratory failure (n=3), shock (n=3), and sepsis associated with cholangitis (n=1). The local complications, in turn, were peripancreatic fluid collection (n=3), pancreatic necroses (n=3), pancreatic pseudocyst (n=1), and pancreatic fistula (n=1). There was only one case of death, which occurred due to acute myocardial infarction and refractory hypocalcemia. The prognostic criteria, according to the number of positive parameters, indicated relative risk (RR) from 4.7 to 11.2, sensitivity from 33.3% to 83.3%, specificity from 79.2% to 98.1%, positive predictive value from 45.0% to 83.3%, negative predictive value from 86.4% to 95.5%, and accuracy from 78.5% to 89.6%. The parameters that presented a separate correlation with severity were white blood cell count >18,000/mm3 , LDH >400 UI/l, 10% decrease in hematocrit levels, serum calcium levels <8 mg/dl, increase in urea nitrogen levels >2 mg/dl, AST >200 mg/dl, LDH >600 UI/l, white cell count >15,000/mm3 , urea >45 mg/dl, arterial pH £7.33 or ³7.49, creatinine levels £0.6 or ³1.4, hematocrit levels £30 or ³45,9, white cell count £3,000 or ³14,900. CONCLUSION: biliary Ranson scores, modified Glasgow scores, APACHE-II and APACHE-O presented good sensitivity and specificity. Multidisciplinary protocols should be implemented in order to achieve optimal treatment results. OBJETIVO: A pancreatite aguda biliar (PAB) é uma doença com morbidade e mortalidade elevadas mas pouco estudada no Brasil. O objetivo deste trabalho é detalhar o diagnóstico diferencial etiológico, a gravidade e o tratamento da PAB no Hospital de Clínicas de Porto Alegre em 1999. MATERIAIS E MÉTODOS: Foram avaliados em estudo de coorte, prospectivo, todos os pacientes com amilase superior a 440 mg/dl e incluídos 65 (78,4%) que apresentavam PAB. Esta amostra foi submetida à determinação de gravidade pelos critérios de Ranson biliar, Glasgow modificado, APACHE-II e APACHE-O e acompanhada durante a evolução da doença. RESULTADOS: Doze pacientes (18,5%) apresentaram evolução clínica com 19 complicações. As sistêmicas foram: falência renal (n = 4), insuficiência respiratória (n = 3), choque (n = 3) e sepse por colangite (n = 1). As complicações locais foram: coleções líquidas peripancreáticas (n = 3), necroses pancreáticas (n = 3), pseudocisto pancreático (n = 1), fístula pancreática (n = 1). Houve apenas uma morte relacionada a infarto agudo do miocárdio e hipocalcemia refratária. Os critérios prognósticos, conforme o número de parâmetros positivos, apresentaram um risco relativo que variou de 4,7 a 11,2, sensibilidade de 33,3% a 83,3%, especificidade de 79,2% a 98,1%, valor preditivo positivo de 45,0% a 83,3%, valor preditivo negativo de 86,4% a 95,5% e acurácia de 78,5% a 89,6%. Isoladamente, os parâmetros que apresentaram correlação com a gravidade foram leucograma >18000/mm3 , LDH >400 UI/L, queda ³10% hematócrito, cálcio sérico <8 mg/dL, aumento do nitrogênio uréico >2 mg/dL, AST >200 mg/dL, LDH >600 UI/L, leucograma >15000 mm3 , uréia >45 mg/dL, pH arterial £7,33 ou ³7,49, creatinina £0,6 ou ³1,4, Ht £30 ou ³45,9, leucócitos £ 3 ou ³14,9 (mil). CONCLUSÕES: Os critérios de Ranson, Glasgow, APACHE-II e APACHE-O apresentam boa sensibilidade e especificidade. O manejo da PAB deve ser revisto a partir de protocolos institucionais multidisciplinares.HCPA/FAMED/UFRGS2022-07-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/125708Clinical & Biomedical Research; Vol. 21 No. 1 (2001): Revista HCPAClinical and Biomedical Research; v. 21 n. 1 (2001): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/125708/85365http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessB. Osvaldt, Alessandro Viero, Priscila T. B. da Costa, Mário Sérgio P. Bersch, Vivian Wendt, Luiz Roberto Rohde, Luiz 2022-07-07T12:08:13Zoai:seer.ufrgs.br:article/125708Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-07-07T12:08:13Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Acute biliary pancreatitis: a prospective cohort study
Pancreatite aguda biliar: um estudo de coorte prospectivo
title Acute biliary pancreatitis: a prospective cohort study
spellingShingle Acute biliary pancreatitis: a prospective cohort study
B. Osvaldt, Alessandro
Pancreatite aguda
biliar
gravidade
prognóstico
Severity
acute pancreatitis
biliary pancreatitis
title_short Acute biliary pancreatitis: a prospective cohort study
title_full Acute biliary pancreatitis: a prospective cohort study
title_fullStr Acute biliary pancreatitis: a prospective cohort study
title_full_unstemmed Acute biliary pancreatitis: a prospective cohort study
title_sort Acute biliary pancreatitis: a prospective cohort study
author B. Osvaldt, Alessandro
author_facet B. Osvaldt, Alessandro
Viero, Priscila
T. B. da Costa, Mário Sérgio
P. Bersch, Vivian
Wendt, Luiz Roberto
Rohde, Luiz
author_role author
author2 Viero, Priscila
T. B. da Costa, Mário Sérgio
P. Bersch, Vivian
Wendt, Luiz Roberto
Rohde, Luiz
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv B. Osvaldt, Alessandro
Viero, Priscila
T. B. da Costa, Mário Sérgio
P. Bersch, Vivian
Wendt, Luiz Roberto
Rohde, Luiz
dc.subject.por.fl_str_mv Pancreatite aguda
biliar
gravidade
prognóstico
Severity
acute pancreatitis
biliary pancreatitis
topic Pancreatite aguda
biliar
gravidade
prognóstico
Severity
acute pancreatitis
biliary pancreatitis
description OBJECTIVE: Acute biliary pancreatitis (ABP) is a disease with high morbidity and mortality rates but poorly studied in Brazil. Our objective was to describe the differential  diagnosis for the etiology of ABP and assess the severity and treatment of the disease at the Hospital de Clínicas de Porto Alegre, in 1999. MATERIALS AND METHODS: We carried out a cohort, prospective study in 65 (78.4%) patients who presented amylase greater than 440 mg/dl and acute biliary pancreatitis (ABP). We assessed biliary Ranson scores, modified Glasgow scores, APACHE-II and APACHE-O of our population in order to determine the severity of the disease. These scores and values were followed-up during the evolution of the disease. RESULTS: Twelve patients presented clinical evolution of the disease. The systemic complications were kidney failure (n=4), respiratory failure (n=3), shock (n=3), and sepsis associated with cholangitis (n=1). The local complications, in turn, were peripancreatic fluid collection (n=3), pancreatic necroses (n=3), pancreatic pseudocyst (n=1), and pancreatic fistula (n=1). There was only one case of death, which occurred due to acute myocardial infarction and refractory hypocalcemia. The prognostic criteria, according to the number of positive parameters, indicated relative risk (RR) from 4.7 to 11.2, sensitivity from 33.3% to 83.3%, specificity from 79.2% to 98.1%, positive predictive value from 45.0% to 83.3%, negative predictive value from 86.4% to 95.5%, and accuracy from 78.5% to 89.6%. The parameters that presented a separate correlation with severity were white blood cell count >18,000/mm3 , LDH >400 UI/l, 10% decrease in hematocrit levels, serum calcium levels <8 mg/dl, increase in urea nitrogen levels >2 mg/dl, AST >200 mg/dl, LDH >600 UI/l, white cell count >15,000/mm3 , urea >45 mg/dl, arterial pH £7.33 or ³7.49, creatinine levels £0.6 or ³1.4, hematocrit levels £30 or ³45,9, white cell count £3,000 or ³14,900. CONCLUSION: biliary Ranson scores, modified Glasgow scores, APACHE-II and APACHE-O presented good sensitivity and specificity. Multidisciplinary protocols should be implemented in order to achieve optimal treatment results. 
publishDate 2022
dc.date.none.fl_str_mv 2022-07-07
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/125708
url https://seer.ufrgs.br/index.php/hcpa/article/view/125708
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/125708/85365
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 21 No. 1 (2001): Revista HCPA
Clinical and Biomedical Research; v. 21 n. 1 (2001): Revista HCPA
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767057406885888